Opinion|Videos|January 7, 2025
HPV Self-Collection Screening: What OB/GYNs Should Know
Author(s)Kameelah Phillips, MD, FACOG, NCMP
The panelist discusses the cautions around recent FDA approvals on human papillomavirus (HPV) self-collection, including limitations and sensitivity while emphasizing the importance of patients continuing to see their OB/GYN regularly.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- What are the benefits and limitations of HPV self-collection, and who is it particularly designed for?
- How does the sensitivity of HPV self-collection compare with traditional collection methods?
- How can education about HPV and HPV screening influence screening rates?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Certolizumab pegol receives FDA BTD for adverse pregnancy outcomes in APS
2
PMOS Awareness Month: Watch our expert panel discussion on PMOS
3
Phase 3 LUNA study: atogepant reduces menstrual migraine days vs. placebo
4
Kevin Ault, MD, on the clinician's role in maternal COVID-19 vaccine counseling
5